ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours - Coyle, C; Cafferty, F H; Rowley, S (Contemp Clin Trials, 2016)
, et al; Add-Aspirin investigators.